CD8+ T cell associated scoring model helps prognostic diagnosis and immunotherapy selection in patients with colon adenocarcinoma
Our research introduces a novel prognostic signature based on CD8<sup>+</sup> T cell marker genes, demonstrating significant predictive power for prognosis and immunotherapy response in COAD patients. This model offers a potential tool for improving patient stratification and personalizing treatment strategies.
Authors
- Kuanxue Sun
- M Chen (ORCID: https://orcid.org/0009-0001-3557-056X)
- Zheng Zhao
- Xinqi Gu
Institutions
- Second Military Medical University (CN)
- Zhengzhou City Hospital (CN)
- Pudong Medical Center (CN)
- Zhengzhou Central Hospital (CN)
- Shanghai Pudong New Area Gongli Hospital (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e37998
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fudan University